Articles

February 12, 2026 Alnylam BioVenture Challenge: Supporting the Next Generation of Biotech Leaders The Alnylam BioVenture Challenge is a partnership with Nucleate designed to empower the next generation of biotech leaders. Discover how we're supporting bold scientific ideas to advance the future of medicine. Read More ›
January 21, 2026 Alnylam CEO Yvonne Greenstreet: What Leadership Has Taught Me Alnylam's CEO Yvonne Greenstreet on leadership lessons she's learned in her first five years as CEO and how those lessons are informing our next five year plan. Read More ›
January 21, 2026 Alnylam Recognized by Newsweek as One of America’s Most Responsible Companies for the Four ... Alnylam is proud to be recognized by Newsweek as one of America's Most Responsible Companies for 2026, our 4 year in a row. Read More ›
December 17, 2025 Alnylam Announces Major Expansion of U.S. Pharmaceutical Manufacturing Facility $250 million investment will add new capacity and siRNA enzymatic ligation capabilities to Alnylam's Norton, Massachusetts site Read More ›
December 8, 2025 The Future of Medicine is in Our Genes Additional human genetics data partnerships are helping scientists identify new drug targets, improving the chances of developing effective medicines Read More ›
December 3, 2025 11 Years, 11 Insights: What The Boston Globe Top Place to Work Survey Reveals About Our Su ... We are extremely proud to be recognized once again as a Boston Globe Top Place to Work marking our 11th year in a row on the list. Read More ›
November 18, 2025 Alnylam Challengers: Empowering Frontline Care for Underserved Communities in Boston We are investing $2 million to advance the essential work of Boston’s frontline Care Navigators through Alnylam Challengers, our Read More ›
October 24, 2025 Looking Beyond the Clinic: Putting Patients at the Center of Holistic Care in Transthyreti ... Enhancing understanding of this life-threatening disease and ensuring that care reflects the realities of those living with it are vital goals shared across the Read More ›
October 20, 2025 Alnylam’s Commitment to Health Literacy for All As a patient-centric organization, Alnylam is fully committed to promoting the principles of health literacy as an integral part of our innovation and culture. Read More ›
September 30, 2025 How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster Translating our pioneering work in RNAi not only requires innovation in the lab - it requires innovation in how we make our medicines. Read More ›
Subscribe to Articles